| Literature DB >> 20177448 |
Punam Sachdeva1, B G Patel, B K Patel.
Abstract
Pregnancy is a special physiological condition where drug treatment presents a special concern because the physiology of pregnancy affects the pharmacokinetics of medications used and certain medications can reach the fetus and cause harm. Total avoidance of pharmacological treatment in pregnancy is not possible and may be dangerous because some women enter pregnancy with medical conditions that require ongoing and episodic treatment (e.g. asthma, epilepsy, hypertension). Also during pregnancy new medical problems can develop and old ones can be exacerbated (e.g. migraine, headache) requiring pharmacological therapy. The fact that certain drugs given during pregnancy may prove harmful to the unborn child is one of the classical problems in medical treatment. In 1960's pregnant ladies who ingested thalidomide gave birth to children with phocomalia. Various other examples of teratogenic effects of drugs are known. It has been documented that congenital abnormalities caused by human teratogenic drugs account for less than 1% of total congenital abnormalities. Hence in 1979, Food and Drug Administration developed a system that determines the teratogenic risk of drugs by considering the quality of data from animal and human studies. FDA classifies various drugs used in pregnancy into five categories, categories A, B, C, D and X. Category A is considered the safest category and category X is absolutely contraindicated in pregnancy. This provides therapeutic guidance for the clinician. This article focuses on various aspects relating to drug use during pregnancy.Entities:
Keywords: FDA categories of drugs; Teratogenic drugs; drug use in pregnancy; physiology of pregnancy
Year: 2009 PMID: 20177448 PMCID: PMC2810038 DOI: 10.4103/0250-474X.51941
Source DB: PubMed Journal: Indian J Pharm Sci ISSN: 0250-474X Impact factor: 0.975
FDA CATEGORIZATION OF DRUGS FOR USE IN PREGNANCY[18]
| Category | Description |
|---|---|
| A | Adequate, well-controlled studies in pregnant women have not shown an increased risk of fetal abnormalities. |
| B | Animal studies have revealed no evidence of harm to the fetus; however, there are no adequate and wellcontrolled studies in pregnant women. Or |
| Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus. | |
| C | Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. Or |
| No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women. | |
| D | Studies, adequate well-controlled or observational, in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. |
| X | Studies, adequate well-controlled or observational, in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. The use of the product is contraindicated in women who are or may become pregnant. |
FDA categorization of drugs for use in pregnancy
COMMONLY USED DRUGS IN PREGNANCY AND THEIR CATEGORIES[19]
| Drugs | Category |
|---|---|
| Analgesics and Antipyretics | B and C |
| Acetaminophen | B |
| Phenacetin | B |
| Aspirin | C |
| Antiemetics | B and C |
| Doxylamine | B |
| Meclizine | B |
| Cyclizine | B |
| Dimenhydrinate | B |
| Antibiotics | B, C and D |
| Penicillin, Ampicillin, Amoxycillin, | B |
| Cloxacillin Cephalosporins | B |
| Erythromycin | B |
| Gentamicin | C |
| Amikacin | C/D |
| Streptomycin | D |
| Sulphonamides | B/D |
| Tetracyclines | D |
| Amoebicides | B |
| Metronidazole | |
| Anthelmentics | B |
| Piperazine | |
| Mebendazole | |
| Antimalarials | C |
| Antifungals | C |
| Anti TB Drugs | B and C |
| Ethambutol | B |
| INH | C |
| Rifampicin | C |
| Pyrazinamide | C |
| PAS | C |
| Vitamins | |
| B,C,D,E,folic acid | A |
| Hormones | |
| Thyroxin | A |
| Androgens | X |
| Estrogens | X |
| Progestogens- | |
| Hydroxyprogestrone | D |
| Medroxyprogestrone | D |
| Norethindrone | X |
| Norgestrel | X |
| Bronchodilators | C |
List of some of the commonly used drugs during pregnancy along with their categories as per FDA categorization
MEDICATIONS CONTRAINDICATED IN PREGNANCY
| Drug | Comments |
|---|---|
| Vitamin A and its derivatives including isotretinein, accutane and etretinate. | Significant risk of spontaneous abortion[ |
| ACE inhibitors | May cause kidney damage in the fetus when used in II and III trimester, decrease in the amount of amniotic fluid and deformities of face, limbs and lungs[ |
| Anticoagulants- warfarin | Use during I trimester produces defects like nasal hypoplasia and a depressed nasal bridge; termed as Fetal warfarin Syndrome. Use during II and III trimesters is associated with increased risk of fetal malformations[ |
| - Heparin | Safe but if taken for long time osteoporosis and decrease in number of platelets in pregnant women occurs[ |
| Estrogen and Androgens | Genital tract malformations[ |
| Thyroid preparations- | |
| Methimazole | Overactive and enlarged Thyroid gland |
| Carbimazole | Overactive and enlarged Thyroid gland |
| Radioactive iodine | Underactive Thyroid gland in fetus |
| Propylthiouracil | Safe[ |
| Anticonvulsants- | |
| Carbamazepine | Risk of birth defects |
| Phenytoin, Phenobarbitone | Bleeding problem in the newborn which can be prevented if pregnant woman takes Vit. K by mouth every day for a month before delivery or if the newborn baby is given an injection of Vit. K soon after birth[ |
| Risk of birth defects. | |
| Trimethadione | Increased risk of miscarriage in the women |
| Sodium valproate | Increased risk of birth defects in fetus; including a cleft palate and abnormalities of the heart, face, skull, hands or abdominal organs[ |
| Antidepressants- Lithium | Birth defects (mainly of the heart), lethargy, decreased muscle tone, underactivity of Thyroid gland and nephrogenic diabetes insipidus in the new born. Ebstein's anomaly (tricuspid valve malformation) has been reported in a number of foetuses exposed to this drug[ |
| NSAIDs | |
| Aspirin and other Salicylates | Delay in start of labor, premature closing of ductus arteriosus, jaundice, brain damage in the fetus and bleeding problems in the woman during and after delivery and in the newborn[ |
| Antibiotics- Tetracycline | Slowed bone growth, permanent yellowing of the teeth and increased susceptibility to cavities in the body[ |
| Chloramphenicol | Gray Baby Syndrome[ |
| Ciprofloxacin | Possibility of joint abnormalities (seen in animals)[ |
| Kanamycin and Streptomycin | Damage to fetus's ear resulting in deafness (risk of ototoxicity)[ |
| Sulfonamides | Jaundice and brain damage in newborn[ |
| Antineoplastic agents- | |
| Busulfan | Birth defects such as less than expected growth before birth, underdevelopment of lower jaw, cleft palate, abnormal development of skull bones, spinal defects, ear defects and club foot[ |
| Chlorambucil | |
| Cyclophosphamide | |
| Methotrexate | |
| Oral Hypoglycemic drugs | A very low level of sugar in the blood of newborn. Inadequate control of
diabetes in the pregnant woman[ |
| Chlorpropamide | |
| Tolbutamide |
List of some of the drugs whose use is contraindicated during pregnancy along with the harmful /damaging effects they may produce on the fetus